Sign in

CIK 0002023658

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$400,716
in 1 filing, $401K under 10b5-1 plans

Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohlhepp Ryan −$401K President, COO & Interim CEO sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2026-08-10 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +12,500 $3.79 $47K 142,355
2026-08-10 Hyep Ivan Chief Financial Officer Sale 10b5-1 −12,500 $27.97 $350K 129,855
2026-08-10 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −12,500 26,336
2026-07-08 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +12,500 $3.79 $47K 157,855
2026-07-08 Hyep Ivan Chief Financial Officer Sale 10b5-1 −22,757 $28.60 $651K 135,098
2026-07-08 Hyep Ivan Chief Financial Officer Sale 10b5-1 −4,413 $29.82 $132K 130,685
2026-07-08 Hyep Ivan Chief Financial Officer Sale 10b5-1 −830 $30.31 $25K 129,855
2026-07-08 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −11,592 58,992
2026-07-08 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −908 38,836
2026-05-21 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +9,200 $3.79 $35K 154,555
2026-05-21 Hyep Ivan Chief Financial Officer Sale 10b5-1 −9,200 $20.42 $188K 145,355
2026-05-21 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −9,200 70,584
2026-04-21 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +9,200 $3.79 $35K 154,555
2026-04-21 Hyep Ivan Chief Financial Officer Sale 10b5-1 −9,200 $23.00 $212K 145,355
2026-04-21 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −9,200 39,744
2026-03-23 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +9,200 $3.79 $35K 154,555
2026-03-23 Hyep Ivan Chief Financial Officer Sale 10b5-1 −9,200 $18.52 $170K 145,355
2026-03-23 Hyep Ivan Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −9,200 48,944
2026-03-04 Hyep Ivan Chief Financial Officer Exercise or conversion 10b5-1 +2,963 $3.79 $11K 148,318
2026-03-04 Hyep Ivan Chief Financial Officer Sale 10b5-1 −2,963 $18.25 $54K 145,355

Page 1 of 3 · 51 trades